DNA Gateway International, Inc. is a specialized provider of corporate development services to biotechnology and pharmaceutical companies.  DNA Gateway assists non-US companies with their efforts entering into the US marketplace.

Core Services include: Strategy & Technology Development, Alliances and Partnerships, Marketing and PR, Legal/IP Issues, Funding Opportunities, Biologics Manufacturing & Approval

biopharma insight VOL1 Issue 3 Q4 - The Competitive Intelligence Issue:
Competitive Intelligence: Key Component of Corporate Decision Making
Biotech Alliances IntelligenceThe Recap Portfolio
Life Science Consulting:An Intelligence Source for Biofinance
Competitive Analysis: A Juxtaposition
Competitive Intelligence & Counter-Intelligence

VOL1 Issue 1
VOL1 Issue 2

 

CALENDAR
  • November 11-13, 2009
    Texas Life Science Conference 2009
    The Brown Foundation Institute of Molecular Medicine
    Houston, Texas
    More 
     
  • November 2-4, 2009
    BIO-Europe 2009
    Messe Wien Exhibition & Congress Center
    Vienna, Austria
    More 
     
  • October 22-16, 2009
    BioProcess International Conference and Exhibition
    Raleigh Convention Center
    Raleigh-Durham, NC
    More 
     

NEWS

  • December 10, 2009
    Azaya Therapeutics Receives FDA Authorization to Start Phase I Cancer Trial
    More 
     
  • Cell Therapy is Alive and Well
    By Cori Gorman, Ph.D., MBA, DNA Bridges, Inc.
    Featured in Bio Show Daily, Tuesday, May 19, 2009. Page 22
    More 
     
  • Personalized Medicine Can Increase Revenues
    By Cammie Edwards, Ph.D., DNA Bridges, Inc.
    Featured in Bio Show Daily, Tuesday, May 19, 2009. Page 33.
    More 
     
  • October 5, 2009
    Depomed, Inc. Announces Positive Top-Line Results from Phase 3 Clinical Trial of DM-1796 in Postherpetic Neuralgia
    Menlo Park, Calif
    More 
     
  • August 10, 2009
    Depomed Reports Encouraging Results of its Phase I Trial for DM-1992 Program in Parkinson's Disease
    Menlo Park, Calif
    More 
     
  • September 22, 2009
    Selexis and Neogenix Oncology enter into research services agreement
    Geneva, Switzerland, and Great Neck, New York
    More 
     
  • September 18, 2009
    Wyeth and Ambrx Form Multi-target Alliance to Leverage Recent Ambrx Biologics Platform Advances
    Collegeville, PA and San Diego, CA
    More 
     
  • September 17, 2009
    to-BBB technology will be used by MedImmune to evaluate brain drug delivery mechanism
    Leiden, The Netherlands
    More 
     
  • August 31, 2009
    Selexis and NKT Therapeutics enter into research services agreement
    Geneva, Switzerland
    More 
     
  • August 6, 2009
    to-BBB climbs up the international CNS drug delivery ranking
    Leiden, The Netherlands
    More 

     

more news...


home | services | clients | our dna | news | contact us

Copyright © DNA Gateway International 2008. All Rights Reserved. Privacy Policy